204510-88-3

Upstream product

• 4163-60-4 β-D-galactose peracetate 
• 13992-26-2 (2R,3S,4S,5R,6R)-2-(acetoxymethyl)-6-azidotetrahydro-2H-pyran-3,4,5-triyl triacetate 
• 1125-88-8 benzaldehyde dimethyl acetal 
• 35899-89-9 1-amido-1-deoxygalactopyranose 
• 100-39-0 benzyl bromide 
• 204510-86-1 4,6-O-benzylidene-β-D-galactopyranosyl azide 

Downstream Products

• 1424335-87-4 1-(4',6'-O-benzylidene-2',3'-di-O-benzyl-β-D-galactosyl)-4-(p-tolyl)-1,2,3-triazole 
• 566199-65-3 Benzoic acid (2R,3S,4S,5R,6R)-6-azido-4,5-bis-benzyloxy-3-hydroxy-tetrahydro-pyran-2-ylmethyl ester 
• 204510-90-7 2,3,6-tri-O-benzyl-β-D-galactopyranosyl azide 

Relevant academic research and scientific papers

Reverse-CD mimics with flexible linkages offer adaptable cavity sizes for guest encapsulation

Reverse-CD mimics with adaptable cavity sizes have been synthesized. The adaptability has been demonstrated through single crystal structure determination and guest binding studies.

A galabiose-based two-dimensional scaffold for the synthesis of inhibitors targeting Pk- and P-antigen binding proteins

A disaccharide scaffold based on galabiose (Galα1-4Gal) was synthesized. Four different acceptors were evaluated in the α-galactosylation and a relationship between the nucleophilicity, yield, and α/β-selectivity was found. The scaffold contains two ortho